News und Analysen

P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable

Celcuity (NASDAQ:CELC), a clinical-stage biotechnology company developing targeted therapies for cancer, released its second quarter 2025 earnings on August 14, 2025. The highlight was topline Phase

Co-Diagnostics (NASDAQ:CODX), a diagnostics technology company focused on infectious disease testing, announced its Q2 2025 results on August 14, 2025. GAAP EPS loss of $0.23 was better than

Daré Bioscience (NASDAQ:DARE), a women’s health-focused biopharmaceutical company developing new therapies and devices, announced its second quarter 2025 results on August 14, 2025. The headline

Shares of department store company Dillard's (NYSE: DDS) rallied on Thursday, up 5.4% as of 2 p.m. ET.

Dillard's reported second-quarter earnings that, while certainly not eye-opening from a growth

Advance Auto Parts(NYSE:AAP) reported second-quarter 2025 results on Aug. 14, 2025, with GAAP net sales of $2 billion, down 8% year-over-year, and adjusted earnings per share (EPS) of $0.69. The

Amcor(NYSE:AMCR) reported fiscal fourth quarter 2025 results on August 14, 2025, highlighting the completed Berry Global acquisition, new synergy targets, and a comprehensive portfolio review

Shares of leading enterprise software provider Nice (NASDAQ: NICE) had dropped 7% as of 11 a.m. ET on Thursday, according to data provided by S&P Global Market Intelligence. Nice reported

Applied Industrial Technologies(NYSE:AIT) reported its fiscal fourth quarter ended June 30, 2025, earnings on August 14, 2025, delivering record full-year sales, EBITDA, and EPS for the fiscal year

Ideal Power (NASDAQ:IPWR), a developer of efficient power semiconductor devices, published its second quarter 2025 results on August 14, 2025. The most notable news from the earnings release was a

Applied Industrial Technologies (NYSE:AIT), a major distributor of industrial motion, fluid power, and automation components, reported its fiscal fourth quarter 2025 results on August 14, 2025. The

Air Industries Group (NYSEMKT:AIRI), a supplier of precision components and assemblies for the defense and aerospace industries, released its Q2 2025 earnings report on August 14, 2025. The company

Contango Ore (NYSEMKT:CTGO), an Alaska-focused gold exploration and production company, posted a record quarter in its earnings release on August 13, 2025. The company reported GAAP earnings per

Cocrystal Pharma (NASDAQ:COCP), a clinical-stage biotech focusing on antiviral drug development, released its second quarter 2025 earnings on August 14, 2025. The company’s report highlighted a

CoreCard (NYSE:CCRD), a provider of financial technology software and services, delivered its second quarter 2025 earnings on August 14, 2025. The main highlight was a surge in both revenue and

Galectin Therapeutics (NASDAQ:GALT), a clinical-stage biotech firm focused on liver fibrosis and cancer, reported its second quarter 2025 results on August 14, 2025. The most significant news was a

Qxo (NYSE:QXO), a rapidly transforming distributor of building products, released its second quarter earnings for fiscal 2025 on August 14, 2025. The most notable news was that it recorded Adjusted

FitLife Brands (NASDAQ:FTLF), a nutritional supplements company with products spanning sports nutrition, weight management, and general wellness, released its financial results for the second

Atai Life Sciences (NASDAQ:ATAI), a biotechnology company developing novel treatments for mental health conditions, reported its results for the second quarter of fiscal 2025 on August 14, 2025. The

Werewolf Therapeutics (NASDAQ:HOWL), an early-stage biotechnology company dedicated to innovative cancer immunotherapies, reported its second quarter 2025 results on August 14, 2025. The main story

Bk Technologies (NYSEMKT:BKTI), a public safety radio and communications equipment provider, released its second quarter fiscal 2025 results on August 14, 2025. The company posted a major earnings

Protalix BioTherapeutics (NYSEMKT:PLX), a biopharmaceutical company specializing in plant cell-based protein production, announced its second quarter results on August 14, 2025. Revenues from

Deere & Company (NYSE:DE), a leading manufacturer of agricultural, construction, and forestry equipment, reported results for fiscal Q3 2025 (ended July 27, 2025) on August 14, 2025. The company

Applied Therapeutics (NASDAQ:APLT), a biotechnology company focused on developing treatments for rare metabolic diseases, reported earnings results for Q2 2025 on August 13, 2025. The main news from